lexiara

12.

A designated orphan medicinal product shall be removed from the Community Register of Orphan Medicinal Products: at the request of the sponsor; if it is established before the market authorisation is granted that the criteria laid down in Article 3 are no longer met in respect of the medicinal product concerned; at the end of the period of market exclusivity as laid down in Article 8.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-21 · Text as adopted (Official Journal); later amendments are not incorporated in this text.